Synthetic Biology Platforms Market Report 2025 (Global Edition)

Global Synthetic Biology Platforms Market Report 2025 Market Size Split by Tool (Oligonucleotides and Synthetic DNA, Enzymes, Cloning Technologies Kits, Synthetic Cells, Chassis Organisms, Xeno-nuclei...

Synthetic Biology Platforms Market Report Description

We have various report editions of Synthetic Biology Platforms Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Competitive Landscape of the Synthetic Biology Platforms Market

The competitive landscape of the synthetic biology platforms market is characterized by intense rivalry among key players striving to innovate and expand their product portfolios. Market leaders focus on research and development, strategic partnerships, and mergers to maintain their competitive edge and capture a larger market share.

Synthetic Biology Platforms Industry News

In November 2023, Thermo Fisher collaborated with Flagship Pioneering to establish new life science tool start-up. Extending their partnership, they announced intentions to jointly create, nurture, and scale innovative platform companies. These ventures will focus on pioneering tools and capabilities, with the goal of bolstering the development of cutting-edge therapies. 

(Source: https://ir.thermofisher.com/investors/news-events/news/news-details/2023/Thermo-Fisher-Scientific--Flagship-Pioneering-Expand-Ongoing-Strategic-Partnership-to-Jointly-Create-New-Platform-Companies-with-First-in-Class-Enabling-Technologies-for-Life-Sciences/default.aspx)  

Top Companies Market Share in Synthetic Biology Platforms Industry: (In no particular order of Rank)

• GenScript
• Thermo Fisher Scientific Inc
• Amyris Inc
• Integrated DNA Technologies
• Du Pont De Nemours and Company
• Precigen Inc (Intrexon Corporation)
• New England Biolabs Inc.
• Novozymes A/S
• Koninklijke DSM N V
• Synthetic Genomics Inc
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Synthetic Biology Platforms Market

Which Region will Dominate the Synthetic Biology Platforms Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024 and accounted for around 40% of the global revenue attributed to several factors. Firstly, the region boasts advanced healthcare infrastructure, fostering widespread adoption of synthetic biology platforms for drug discovery and development. Moreover, a robust biotechnology ecosystem and substantial R&D investments drive innovation, propelling market growth. Additionally, supportive government initiatives and favourable regulatory frameworks stimulate market expansion. Lastly, strategic collaborations between industry players and academic institutions enhance research capabilities, further fuelling sales.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is the fastest-growing region due to various factors. Increasing investments in biotechnology and life sciences, particularly in countries like China and India, drive market expansion. Additionally, growing awareness of personalized medicine and gene therapy fuels demand for synthetic biology platforms. Furthermore, the availability of skilled labour at competitive costs and a burgeoning pharmaceutical industry contribute to the region's accelerated growth. Moreover, favourable government policies and initiatives aimed at promoting biotechnology research and development attract investments and spur innovation in the Asia-Pacific market.

The current report Scope analyzes Synthetic Biology Platforms Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

North America Synthetic Biology Platforms Market Analysis

According to Cognitive Market Research, the global synthetic biology platforms market size was estimated at USD 13515.2 Million out of which North America held the major market of around 40% of the global revenue with a market size of USD 5406.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 26.8% from 2024 to 2031. The region's strong focus on innovation and technological advancements, coupled with supportive regulatory frameworks, drives market growth. Additionally, increasing demand for personalized medicine and gene therapies fuels sales. Moreover, strategic collaborations between academia, industry, and government entities foster innovation and accelerate market expansion. In North America, enzymes hold the highest market share, poised for further growth fuelled by their integral role in various synthetic biology processes and the region's emphasis on bio production and healthcare applications.

Country Analysis

• According to Cognitive Market Research, The United States synthetic biology platforms market had a market share of USD 4265.40 million in 2024 and is projected to grow at a CAGR of 26.6% during the forecast period. Sales in the U.S. surge due to robust investments in biotechnology, fostering innovation. The nation's strong biopharmaceutical sector and favourable regulatory environment further drive demand for synthetic biology platforms.
• Canada synthetic biology platforms market had a market share of USD 648.73 million in 2024 and is projected to grow at a CAGR of 27.6% during the forecast period. Canada sees increased sales as the government boosts funding for biotechnology research. The country's burgeoning biotech industry and focus on sustainable agriculture drive adoption of synthetic biology platforms.
• Mexico synthetic biology platforms market had a market share of USD 491.95 million in 2024 and is projected to grow at a CAGR of 27.3% during the forecast period.

Europe Synthetic Biology Platforms Market Analysis

According to Cognitive Market Research, with a market value of USD 13515.2 million in 2024 and projected to expand at a compound annual growth rate (CAGR) of 27.1% from 2024 to 2031. Europe accounted for a share of around 30% of the global market size of USD 4054.56 million. The region's rich scientific heritage and collaborative research environment propel innovation in synthetic biology. Additionally, supportive government policies and funding initiatives bolster R&D activities and drive market growth. Moreover, increasing adoption of sustainable bio production practices and advancements in genome editing technologies contribute to sales expansion. Furthermore, Europe's emphasis on environmental sustainability and bio-based industries fuels demand for synthetic biology platforms. In Europe, gene synthesis emerges as the highest market share segment, poised for growth driven by demand from diverse industries and research sectors.

• The United Kingdom synthetic biology platforms market had a market share of USD 681.17 million in 2024 and is projected to grow at a CAGR of 27.9% during the forecast period. In the UK, sales rise owing to a supportive regulatory landscape and strong research infrastructure. Growing demand for personalized medicine and bio-based products fuels adoption of synthetic biology platforms.
• France synthetic biology platforms market had a market share of USD 373.02 million in 2024 and is projected to grow at a CAGR of 26.3% during the forecast period.
• Germany synthetic biology platforms market had a market share of USD 802.80 million in 2024 and is projected to grow at a CAGR of 27.3% during the forecast period. Germany experiences sales growth fuelled by its leadership in biotechnology and strong emphasis on innovation. The country's focus on sustainable development and industrial bio manufacturing drives demand for synthetic biology platforms.
• Italy synthetic biology platforms market had a market share of USD 348.69 million in 2024 and is projected to grow at a CAGR of 26.5% during the forecast period.
• Russia synthetic biology platforms market had a market share of USD 628.46 million in 2024 and is projected to grow at a CAGR of 26.1% during the forecast period.
• Spain synthetic biology platforms market had a market share of USD 332.47 million in 2024 and is projected to grow at a CAGR of 26.2% during the forecast period.
• Luxembourg's synthetic biology platforms market had a market share of USD 125.69 million in 2024 and is projected to grow at a CAGR of 27.2% during the forecast period.
• Portugal's synthetic biology platforms market had a market share of USD 85.15 million in 2024 and is projected to grow at a CAGR of 26.9% during the forecast period.
• Greece's synthetic biology platforms market had a market share of USD 48.65 million in 2024 and is projected to grow at a CAGR of 27.4% during the forecast period.
• The rest of Europe synthetic biology platforms market had a market share of USD 628.46 million in 2024 and is projected to grow at a CAGR of 25.8% during the forecast period.

Asia Pacific Synthetic Biology Platforms Market Analysis

According to Cognitive Market Research, the global synthetic biology platforms market size was estimated at USD 13515.2 Million out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 3108.50 million in 2024 and will grow at a compound annual growth rate (CAGR) of 30.6% from 2024 to 2031. The region's burgeoning biotechnology sector, coupled with increasing investments in research and development, drives innovation and market expansion. Additionally, rising healthcare expenditure and the prevalence of chronic diseases stimulate demand for synthetic biology solutions. Moreover, Asia Pacific's focus on precision agriculture and sustainable food production propels sales of synthetic biology platforms in the agricultural sector. In Asia Pacific, artificial tissue and tissue regeneration emerge as the highest market share segment, driven by the region's growing emphasis on regenerative medicine and healthcare advancements.

• According to Cognitive Market Research, The China synthetic biology platforms market had a market share of USD 1398.82 million in 2024 and is projected to grow at a CAGR of 30.1% during the forecast period. In China, sales soar due to government initiatives promoting biotechnology innovation. The nation's expanding biopharmaceutical industry and investments in precision medicine drive adoption of synthetic biology platforms.
• Japan synthetic biology platforms market had a market share of USD 428.97 million in 2024 and is projected to grow at a CAGR of 29.1% during the forecast period.
• India synthetic biology platforms market had a market share of USD 373.02 million in 2024 and is projected to grow at a CAGR of 32.4% during the forecast period. India sees increased sales driven by its growing biotech sector and emphasis on healthcare innovation. Rising demand for affordable healthcare solutions and genetic research fuel adoption of synthetic biology platforms.
• South Korea synthetic biology platforms market had a market share of USD 310.85 million in 2024 and is projected to grow at a CAGR of 29.7% during the forecast period.
• Australia synthetic biology platforms market had a market share of USD 161.64 million in 2024 and is projected to grow at a CAGR of 30.3% during the forecast period.
• South East Asia synthetic biology platforms market had a market share of USD 214.49 million in 2024 and is projected to grow at a CAGR of 31.6% during the forecast period.
• Rest of Asia Pacific synthetic biology platforms market had a market share of USD 220.70 million in 2024 and is projected to grow at a CAGR of 30.4% during the forecast period.

 

South America Synthetic Biology Platforms Market Analysis

According to Cognitive Market Research, the global synthetic biology platforms market size was estimated at USD 13515.2 Million out of which Latin America market of around 5% of the global revenue with a market size of USD 675.76 million in 2024 and will grow at a compound annual growth rate (CAGR) of 28.0% from 2024 to 2031. The region's increasing healthcare expenditure and government initiatives to enhance healthcare infrastructure drive adoption of synthetic biology solutions for drug discovery and personalized medicine. Additionally, Latin America's rich biodiversity fuels bioprospecting efforts, contributing to the demand for synthetic biology platforms in bio-discovery applications. Moreover, the region's focus on sustainable agriculture and bio-based industries stimulates sales in the agricultural and industrial sectors. In Latin America, medical applications hold the highest market share, poised for further growth driven by increasing demand for innovative healthcare solutions

• According to Cognitive Market Research, The Brazil synthetic biology platforms market had a market share of USD 289.23 million in 2024 and is projected to grow at a CAGR of 28.6% during the forecast period. Brazil experiences sales growth as the government invests in biotechnology and sustainable agriculture. The nation's rich biodiversity and focus on bio-based industries drive adoption of synthetic biology platforms.
• Argentina synthetic biology platforms market had a market share of USD 113.53 million in 2024 and is projected to grow at a CAGR of 28.9% during the forecast period. Sales in Argentina rise due to investments in agricultural biotechnology and biofuels. The nation's emphasis on genetic research and sustainable farming practices fuel adoption of synthetic biology platforms.
• Colombia synthetic biology platforms market had a market share of USD 60.14 million in 2024 and is projected to grow at a CAGR of 27.8% during the forecast period.
• Peru synthetic biology platforms market had a market share of USD 55.41 million in 2024 and is projected to grow at a CAGR of 28.2% during the forecast period.
• Chile synthetic biology platforms market had a market share of USD 48.65 million in 2024 and is projected to grow at a CAGR of 28.3% during the forecast period.
• Rest of Latin America synthetic biology platforms market had a market share of USD 108.80 million in 2024 and is projected to grow at a CAGR of 27.1% during the forecast period.

Middle East Synthetic Biology Platforms Market Analysis

According to Cognitive Market Research, the global synthetic biology platforms market size was estimated at USD 13515.2 Million out of which Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 270.30 million in 2024 and will grow at a compound annual growth rate (CAGR) of 28.3% from 2024 to 2031. The MEA synthetic biology platforms market experiences growth driven by unique factors. The region's focus on diversifying economies and reducing dependence on oil revenues fuels investments in biotechnology and innovation. Additionally, increasing healthcare expenditure and government initiatives to enhance healthcare infrastructure contribute to market growth. Moreover, MEA's rich biodiversity presents opportunities for bioprospecting and bio-discovery applications, driving demand for synthetic biology platforms. In MEA, genome engineering emerges as the highest market share segment, poised for growth driven by applications in agriculture, healthcare, and bioremediation efforts.

• According to Cognitive Market Research, The GCC Countries synthetic biology platforms market had a market share of USD 115.69 million in 2024 and is projected to grow at a CAGR of 29.1% during the forecast period. GCC Countries witness sales growth driven by diversification efforts and investments in biotechnology. The region's focus on healthcare innovation and sustainable energy solutions spur adoption of synthetic biology platforms.
• Egypt synthetic biology platforms market had a market share of USD 28.38 million in 2024 and is projected to grow at a CAGR of 28.6% during the forecast period.
• South Africa synthetic biology platforms market had a market share of USD 42.71 million in 2024 and is projected to grow at a CAGR of 29.3% during the forecast period. In South Africa, sales increase as the nation invests in biotechnology research and development. The country's focus on healthcare accessibility and sustainable agriculture drives adoption of synthetic biology platforms.
• Turkey synthetic biology platforms market had a market share of USD 23.25 million in 2024 and is projected to grow at a CAGR of 27.8% during the forecast period.
• Nigeria synthetic biology platforms market had a market share of USD 28.38 million in 2024 and is projected to grow at a CAGR of 27.4% during the forecast period.
• Rest of MEA synthetic biology platforms market had a market share of USD 31.90 million in 2024 and is projected to grow at a CAGR of 27.3% during the forecast period.

Synthetic Biology Platforms Market Analysis

Synthetic Biology Platforms Market Tool Segment Analysis

According to Cognitive Market Research, enzymes held the major market share over the forecast period due to their crucial role in various synthetic biology processes, driving sales. With increasing applications in gene editing, DNA synthesis, and protein engineering across industries such as healthcare, agriculture, and biotechnology, demand for enzymes remains high. Moreover, advancements in enzyme engineering techniques and the development of novel biocatalysts further stimulate market growth. Additionally, the growing trend towards sustainable bio production processes fuels the adoption of enzymes in bio-based manufacturing.

Oligonucleotides and synthetic DNA is the fastest-growing category over the forecast period owing to several factors. The rising demand for custom DNA constructs for gene editing, gene synthesis, and genetic engineering applications drives sales. Additionally, technological advancements in DNA synthesis techniques, such as high-throughput synthesis and gene assembly methods, enhance production efficiency and scalability, further boosting market growth. Moreover, increasing research activities in fields like personalized medicine, synthetic biology, and biotechnology contribute to the segment's expansion.

• Oligonucleotides and Synthetic DNA
• Enzymes
• Cloning Technologies Kits
• Synthetic Cells
• Chassis Organisms
• Xeno-nucleic Acids

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Synthetic Biology Platforms Industry. Request a Free Sample PDF!

Synthetic Biology Platforms Market Technology Segment Analysis

According to Cognitive Market Research, gene synthesis hold a prominent market share due to several factors. The increasing demand for custom DNA constructs for gene editing, genetic engineering, and synthetic biology applications drives sales. Moreover, advancements in gene synthesis technologies, such as high-throughput methods and error correction techniques, enhance efficiency and accuracy, further stimulating market growth. Additionally, the expanding applications of gene synthesis in fields like gene therapy, personalized medicine, and bio production contribute to the segment's sustained dominance.

Genome engineering is the fastest-growing category over the forecast period driven by various factors. The widespread adoption of CRISPR/Cas9 and other genome editing tools for precise genetic modifications fuels sales. Moreover, increasing research in areas like gene therapy, agricultural biotechnology, and disease modelling drives demand for genome engineering technologies. Additionally, advancements in delivery methods, such as viral vectors and nanoparticles, enhance the efficiency and applicability of genome editing techniques, further accelerating market growth.

• Gene Synthesis
• Genome Engineering
• Sequencing
• Bioinformatics
• Site-directed Mutagenesis
• Cloning
• Measurement and Modelling
• Microfluidics
• Nanotechnology

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Synthetic Biology Platforms Application Segment Analysis

According to Cognitive Market Research, medical application hold a prominent market share due to several factors. The increasing prevalence of chronic diseases and genetic disorders drives demand for advanced therapeutic solutions, such as gene therapies and personalized medicine. Moreover, ongoing research in areas like regenerative medicine and cancer immunotherapy boosts the adoption of synthetic biology platforms in medical settings. Additionally, collaborations between pharmaceutical companies and research institutions expedite the development and commercialization of novel treatments, further propelling market growth.

Artificial tissue and tissue regeneration is the fastest-growing category over the forecast period driven by various factors. The growing need for alternative solutions to organ transplantation and tissue repair fuels demand for artificial tissue and tissue regeneration technologies. Additionally, advancements in biomaterials, scaffold designs, and tissue engineering techniques enhance the efficacy and applicability of artificial tissue constructs, further stimulating market expansion. Moreover, increasing investments in regenerative medicine research and rising prevalence of degenerative diseases drive innovation and adoption in this segment.

• Medical Application
• Drug Discovery and Therapeutics
• Artificial Tissue and Tissue Regeneration
• Bio-synthesis
• Stem Cell Regulation
• Other Tissue and Tissue Regeneration Applications
• Industrial Applications
• Biofuel and Renewable Energy
• Biomaterials and Green Chemicals
• Industrial Enzymes
• Food & Agriculture
• Environmental Applications

Author's Detail

Swasti Dharmadhikari

Research associate at Cognitive Market Research

LinkedIn

Profile

Swasti Dharmadhikari, an agile and achievement-focused market researcher with an innate ardor for deciphering the intricacies of the Service & Software sector. Backed by a profound insight into technology trends and consumer dynamics, she has committed herself to meticulously navigating the ever-evolving terrain of digital Services and software solutions.

Author's Conclusion